BURLINGTON, N.C., June 9, 2023 /PRNewswire/ — Labcorp (NYSE: LH), a leading global life sciences company, today announced the following record and distribution dates for the spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp (“Fortrea”): The record date will be 5 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and … Read more
BIOTRONIK continues to champion diversity in clinical trial enrollment with ongoing BIO-LIBRA Study LAKE OSWEGO, Ore., June 9, 2023 /PRNewswire/ — Data presented at Heart Rhythm Society’s 2023 Conference show a measurable difference in outcomes between male and female patients when looking at one-year ventricular tachyarrhythmia or death rates in patients with non-ischemic cardiomyopathy (NICM) … Read more
THOUSAND OAKS, Calif., June 9, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 44th Annual Global Healthcare Conference at 2:20 p.m. ET on Wednesday, June 14, 2023. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and … Read more
DUBLIN, June 9, 2023 /PRNewswire/ — The “Gene Amplification Technologies Market Report 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The Gene Amplification Technologies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be … Read more
ALLEGAN, Mich., June 9, 2023 /PRNewswire/ — Padagis today announced the launch of Tazarotene Gel (generic to Tazorac® Gel) and Methylphenidate Transdermal System (authorized generic to Daytrana®). Tazorac® Gel 0.05% and 0.1% are indicated for the topical treatment of patients with plaque psoriasis of up to 20% body surface area involvement. Tazorac® Gel 0.1% is … Read more
SILVER SPRING, Md., June 9, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA provided information to health care providers and facilities on oxygenator devices used in extracorporeal circulation. The FDA issued this letter to help ensure that health care … Read more
To understand the causes of the crisis and ultimately to find solutions, we address three critical post-pandemic trends. ESSEX, N.Y., June 9, 2023 /PRNewswire/ — COVID-19 wreaked havoc on K-12 and postsecondary education across the U.S. Test scores in foundational subject areas such as reading and math fell to their lowest levels in decades, absenteeism … Read more
ESTERO, Fla., June 9, 2023 /PRNewswire/ — Elite Events is excited to announce the highly anticipated USA Independence Day 5K, a spirited race set for July 4th at Hertz Arena in Estero, Florida. This event promises an unforgettable experience filled with fitness, patriotism, and exciting…
DUBLIN, June 9, 2023 /PRNewswire/ — The “Contact Lenses: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. The increasing prevalence of eye disorders such as astigmatism and myopia is a crucial growth factor for the contact lens market. An ageing population, increased affordability, and technological advancements and innovations are other growth factors … Read more
CAMBRIDGE, Mass., June 9, 2023 /PRNewswire/ — Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today presented updated preliminary data from the ongoing Phase 1/2 study evaluating TP-3654, an investigational selective oral PIM1 kinase inhibitor, in patients with myelofibrosis (MF) previously treated with or ineligible for JAK inhibitor therapy. Initial preliminary … Read more